Gene Synthesis and Editing Tools accessible in China

Thermo Fisher Scientific is offering its portfolio of Invitrogen GeneArt products and services in China to met increasing demand for genome editing and gene synthesis technologies. Helge Bastian, vice president and general manager of synthetic biology at Thermo Fisher said: “GeneArt products will not only enable our customers to continually enhance our understanding of how biology works, it will also help them accelerate the path from planning experiments to executing them in the lab."

The product line includes a Gene Synthesis Service, GeneArt Strings DNA Fragments and Libraries and GeneArt Genome Editing Tools.

"Thermo Fisher's GeneArt technology was integral in our research on insect resistance and molecular toxicology," said Yi-Hua Yang, professor at the College of Plant Protection, Nanjing Agricultural University. "The technology not only enabled us to knock out and validate a receptor for Bt toxins used in insect controls, we were also able to demonstrate that the CRISPR-Cas9 technique can act as a powerful and efficient genome editing tool to study gene function in a global agricultural pest."